About Anne D Pham

This author has not yet filled in any details.
So far Anne D Pham has created 54 blog entries.

Randy Fishman

2021-10-11T17:24:12+00:00

Randy Fishman Randy Fishman is a member of the Board of Directors of Citymeals on Wheels, and New York City Ballet. Mrs. Fishman also devotes much of her time to continuing the work that she and her late husband, Jay S. Fishman, began in support of ALS research projects and patient care programs for the ALS community. She is co-founder and member of the Advisory Board of Answer ALS. In addition, Mrs. Fishman is a founder and key advisor to both the ALS Augmentative Communication Program at Boston Children’s Hospital and the Home Assisted Ventilation Program at [...]

Randy Fishman2021-10-11T17:24:12+00:00

Richard G. Ellenbogen

2021-10-11T17:16:48+00:00

Richard G. Ellenbogen, MD, F.A.C.S Richard G. Ellenbogen, MD, F.A.C.S is the Chair and the Theodore Roberts Endowed Professor of the Department of Neurological Surgery at the University of Washington in Seattle, WA. In addition, he is Director of the Neurological Surgery Residency Program and Director of the UW Medicine Neurosciences Institute. His numerous clinical interests include pediatric and adult brain tumors, trauma surgery, congenital malformations, and minimally invasive endoscopic brain surgery. Dr. Ellenbogen has served as Chair, American Board of Neurological Surgeons; President, Congress of Neurological Surgeons (CNS); President, The American Society of Pediatric Neurological Surgery; [...]

Richard G. Ellenbogen2021-10-11T17:16:48+00:00

Merit Cudkowicz

2021-11-15T14:31:12+00:00

Merit Cudkowicz, MD, MSc Interview Merit Cudkowicz, MD, MSc is the Chief of the Massachusetts General Hospital Neurology Service, Director, Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, and the Julieanne Dorn Professor of Neurology at Harvard Medical School in Boston. Dr. Cudkowicz is co-founder and former director of the Neurological Clinical Research Institute (NCRI). She is one of the founders and former co-directors of the Northeast ALS Consortium (NEALS), a group of over 100 clinical sites in the United States, Canada, Europe and the Middle East dedicated to performing collaborative academic led [...]

Merit Cudkowicz2021-11-15T14:31:12+00:00

Robert Brown D.Phil

2021-10-11T17:25:54+00:00

Robert H. Brown Jr., MD, DPhil Robert H. Brown Jr., MD, DPhil is the director of the Program in Neurotherapeutics at the University of Massachusetts Medical School. Dr. Brown is an internationally known researcher and clinician leading the quest to cure neurodegenerative and neuromuscular diseases like amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. Dr. Brown founded the Day Neuromuscular Laboratory in 1984 to investigate neuromuscular diseases, and continues his work with the Day Lab today at the University of Massachusetts Medical School. In 1993, a team of researchers led by Dr. Brown discovered the [...]

Robert Brown D.Phil2021-10-11T17:25:54+00:00

Stanley H. Appel

2021-11-15T14:31:40+00:00

Stanley H. Appel, MD Interview Stanley H. Appel, MD is the Peggy and Gary Edwards Distinguished Endowed Chair for ALS Research, Chair of the Stanley H. Appel Department of Neurology and Co-Director of the Houston Methodist Neurological Institute. He also serves as Director of the MDA/ALSA ALS Research Clinical Center at Houston Methodist Hospital, and is Professor of Neurology at Weill Cornell Medical College. In August 2020, he was named Director of the Johnson Center for Cellular Therapeutics at the Houston Methodist Research Institute. Research in Dr. Appel’s laboratory has focused on the role of inflammation in [...]

Stanley H. Appel2021-11-15T14:31:40+00:00

Leandro P. Rizzuto

2021-06-28T15:30:29+00:00

Leandro P. Rizzuto Lee Rizzuto grew up in Brooklyn, New York, son of Italian immigrants, both active members of the large and bustling New York City hair salon community. He attended Brooklyn Tech and graduated in 1956. In 1959, Lee and his parents invested $100 to launch Continental Hair Products. The company quickly grew into a trusted source of innovative and affordable products for professional stylists, including the iconic pistol grip hairdryer. Lee's passion for product drove his business, and following his success in the professional arena, he began marketing products to consumers. A relationship with Vidal [...]

Leandro P. Rizzuto2021-06-28T15:30:29+00:00

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial

2021-09-07T16:20:37+00:00

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial Cedars-Sinai has been awarded $11.99 million by California's stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS). ALS, or Lou Gehrig's disease, is a progressive neurodegenerative disease that damages nerve cells known as motor neurons in the brain and spinal cord that control voluntary muscle movement. It affects an estimated 16,000 people in the U.S. and is usually fatal within five years of diagnosis. There is no known cure and only limited treatments that may slow progression [...]

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial2021-09-07T16:20:37+00:00

Healey Center for ALS in partnership with ALS Finding a Cure announces the 2021 ALS Scholars in Therapeutics Recipients

2021-12-15T14:50:48+00:00

Class of 2021 The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) in partnership with ALS Finding a Cure (ALSFAC) selected four recipients for their inaugural global two-year ALS Scholars in Therapeutics program. The program received an outstanding pool of global applications from 6 countries. This year’s selected recipients are Juliet Goldsmith, PhD of University of Pennsylvania, Matthew Anthony White, PhD of Kings College London, Brian Jude Joseph, PhD of Harvard University and Su Min Lim, PhD of Massachusetts General Hospital, Harvard Medical School. Learn about the ALS Scholars Program. [...]

Healey Center for ALS in partnership with ALS Finding a Cure announces the 2021 ALS Scholars in Therapeutics Recipients2021-12-15T14:50:48+00:00

ALSFAC-Funded Project Announces Successful ALS Clinical Trial and High-Profile Publication

2021-09-07T16:20:37+00:00

ALSFAC-Funded Project Announces Successful ALS Clinical Trial and High-Profile Publication Amylyx, a start-up biotech company developing new treatments for ALS supported by ALS Finding a Cure®, and Mass General Hospital, announced the publication of results from its successful pivotal stage ALS clinical trial in the prestigious New England Journal of Medicine (NEJM). ALS Finding A Cure® provided two grants to Amylyx: the first in collaboration with Cure Alzheimer’s Disease to support required preclinical toxicology studies, and the second to fund this trial in collaboration with The ALS Association as part of the ALS ACT initiative.  The clinical trial, known as [...]

ALSFAC-Funded Project Announces Successful ALS Clinical Trial and High-Profile Publication2021-09-07T16:20:37+00:00

ALSFAC Funded Research Turns Off Key Gene in Families with ALS

2021-09-07T16:20:37+00:00

ALSFAC Funded Research Turns Off Key Gene in Families with ALS Researchers at the University of Massachusetts Medical School and Massachusetts General Hospital report progress on a potential new weapon against the fatal nerve disease ALS. Read More Report Progress

ALSFAC Funded Research Turns Off Key Gene in Families with ALS2021-09-07T16:20:37+00:00
Go to Top